A technology company specializing in the application of artificial intelligence to advance precision medicine and patient ...

In the assessment of 12-month price targets, analysts unveil insights for Tempus AI, presenting an average target of $64.09, ...

Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest ...

Boehringer will gain access to the de-identified database of Tempus, which comprises clinical, imaging and molecular data.

"By combining internal, pre-clinical experimental data, with real-world data from Tempus on its AI-powered platform, we can profoundly deepen our understanding of cancer biology and accelerate our ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the presentation of six posters, including one oral ...

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look ...

Tempus AI is gaining traction and on track for profits this year; high short interest and rising institutional activity point ...

The tech industry has been so excited about generative AI that everyone seems to miss a fundamental point: it’s not at all ...

We recently published a list of Why These 10 Stocks Soared Today. In this article, we are going to take a look at where ...

Cathie Wood‘s Ark Invest made notable trades involving Nvidia Corp. NVDA, Advanced Micro Devices Inc. AMD, Palantir ...